Delayed
Canadian Securities Exchange
16:03:46 25/06/2024 BST
|
5-day change
|
1st Jan Change
|
0.035
CAD
|
0.00%
|
|
-12.50%
|
-22.22%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
---|
Capitalization
1 |
18.77
|
61
|
28.15
|
14.08
|
Enterprise Value (EV)
1 |
18.75
|
60.18
|
28.1
|
15.39
|
P/E ratio
|
-5.55
x
|
-19.3
x
|
-6.38
x
|
-4.76
x
|
Yield
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
3,802,904,495
x
|
500,345,631
x
|
742,561,135
x
|
EV / Revenue
|
-
|
3,751,354,841
x
|
499,329,530
x
|
811,716,584
x
|
EV / EBITDA
|
-
|
-
|
-
|
-
|
EV / FCF
|
31,011,582
x
|
26,660,436
x
|
25,918,445
x
|
15,367,715
x
|
FCF Yield
|
0%
|
0%
|
0%
|
0%
|
Price to Book
|
-3.63
x
|
-7.6
x
|
-2.26
x
|
-0.94
x
|
Nbr of stocks (in thousands)
|
312,833
|
312,833
|
312,833
|
312,833
|
Reference price
2 |
0.0600
|
0.1950
|
0.0900
|
0.0450
|
Announcement Date
|
16/07/20
|
28/06/21
|
02/05/22
|
20/10/23
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net sales
|
-
|
-
|
0.016
|
0.0563
|
0.019
|
EBITDA
1 |
-0.0657
|
-
|
-
|
-
|
-
|
EBIT
1 |
-0.0896
|
-0.6625
|
-2.586
|
-4.101
|
-1.521
|
Operating Margin
|
-
|
-
|
-16,119.71%
|
-7,287.7%
|
-8,021.29%
|
Earnings before Tax (EBT)
1 |
-0.0961
|
-2.158
|
-2.895
|
-4.294
|
-2.835
|
Net income
1 |
-2.165
|
-3.305
|
-3.162
|
-4.414
|
-2.96
|
Net margin
|
-
|
-
|
-19,709.24%
|
-7,844.39%
|
-15,615.32%
|
EPS
2 |
-0.007732
|
-0.0108
|
-0.0101
|
-0.0141
|
-0.009463
|
Free Cash Flow
|
-
|
0.6047
|
2.257
|
1.084
|
1.001
|
FCF margin
|
-
|
-
|
14,070.87%
|
1,926.54%
|
5,281.96%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
16/07/20
|
16/07/20
|
28/06/21
|
02/05/22
|
20/10/23
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
1.31
|
Net Cash position
1 |
0
|
0.02
|
0.83
|
0.06
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
0.6
|
2.26
|
1.08
|
1
|
ROE (net income / shareholders' equity)
|
-
|
48%
|
43.9%
|
41.9%
|
20.1%
|
ROA (Net income/ Total Assets)
|
-
|
-53.3%
|
-167%
|
-201%
|
-160%
|
Assets
1 |
-
|
6.201
|
1.891
|
2.195
|
1.851
|
Book Value Per Share
2 |
-0.0100
|
-0.0200
|
-0.0300
|
-0.0400
|
-0.0500
|
Cash Flow per Share
2 |
0
|
0
|
0
|
0
|
0
|
Capex
|
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
16/07/20
|
16/07/20
|
28/06/21
|
02/05/22
|
20/10/23
|
|
1st Jan change
|
Capi.
|
---|
| -22.22% | 8.51M | | +29.99% | 5.69B | | -31.99% | 3.53B | | -0.59% | 3.06B | | -24.15% | 2.62B | | -9.23% | 2.29B | | +42.55% | 1.86B | | +44.37% | 1.43B | | -11.29% | 1.41B | | +42.86% | 1.4B |
Alternative Medicine
|